Macrophage Gene Expression in Adipose Tissue is Associated with Insulin Sensitivity and Serum Lipid Levels Independent of Obesity
Objective: Obesity is linked to both increased metabolic disturbances and increased adipose tissue macrophage infiltration. However, whether macrophage infiltration directly influences human metabolism is unclear. The aim of this study was to investigate if there are obesity‐independent links betwee...
Saved in:
Published in | Obesity (Silver Spring, Md.) Vol. 21; no. 12; pp. E571 - E576 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.12.2013
|
Subjects | |
Online Access | Get full text |
ISSN | 1930-7381 1930-739X 1930-739X |
DOI | 10.1002/oby.20443 |
Cover
Loading…
Abstract | Objective: Obesity is linked to both increased metabolic disturbances and increased adipose tissue macrophage infiltration. However, whether macrophage infiltration directly influences human metabolism is unclear. The aim of this study was to investigate if there are obesity‐independent links between adipose tissue macrophages and metabolic disturbances.
Design and Methods: Expression of macrophage markers in adipose tissue was analyzed by DNA microarrays in the SOS Sib Pair study and in patients with type 2 diabetes and a BMI‐matched healthy control group.
Results: The expression of macrophage markers in adipose tissue was increased in obesity and associated with several metabolic and anthropometric measurements. After adjustment for BMI, the expression remained associated with insulin sensitivity, serum levels of insulin, C‐peptide, high density lipoprotein cholesterol (HDL‐cholesterol) and triglycerides. In addition, the expression of most macrophage markers was significantly increased in patients with type 2 diabetes compared to the control group.
Conclusion: Our study shows that infiltration of macrophages in human adipose tissue, estimated by the expression of macrophage markers, is increased in subjects with obesity and diabetes and associated with insulin sensitivity and serum lipid levels independent of BMI. This indicates that adipose tissue macrophages may contribute to the development of insulin resistance and dyslipidemia. |
---|---|
AbstractList | Objective: Obesity is linked to both increased metabolic disturbances and increased adipose tissue macrophage infiltration. However, whether macrophage infiltration directly influences human metabolism is unclear. The aim of this study was to investigate if there are obesity-independent links between adipose tissue macrophages and metabolic disturbances. Design and Methods: Expression of macrophage markers in adipose tissue was analyzed by DNA microarrays in the SOS Sib Pair study and in patients with type 2 diabetes and a BMI-matched healthy control group. Results: The expression of macrophage markers in adipose tissue was increased in obesity and associated with several metabolic and anthropometric measurements. After adjustment for BMI, the expression remained associated with insulin sensitivity, serum levels of insulin, C-peptide, high density lipoprotein cholesterol (HDL-cholesterol) and triglycerides. In addition, the expression of most macrophage markers was significantly increased in patients with type 2 diabetes compared to the control group. Conclusion: Our study shows that infiltration of macrophages in human adipose tissue, estimated by the expression of macrophage markers, is increased in subjects with obesity and diabetes and associated with insulin sensitivity and serum lipid levels independent of BMI. This indicates that adipose tissue macrophages may contribute to the development of insulin resistance and dyslipidemia. Obesity is linked to both increased metabolic disturbances and increased adipose tissue macrophage infiltration. However, whether macrophage infiltration directly influences human metabolism is unclear. The aim of this study was to investigate if there are obesity-independent links between adipose tissue macrophages and metabolic disturbances.OBJECTIVEObesity is linked to both increased metabolic disturbances and increased adipose tissue macrophage infiltration. However, whether macrophage infiltration directly influences human metabolism is unclear. The aim of this study was to investigate if there are obesity-independent links between adipose tissue macrophages and metabolic disturbances.Expression of macrophage markers in adipose tissue was analyzed by DNA microarrays in the SOS Sib Pair study and in patients with type 2 diabetes and a BMI-matched healthy control group.DESIGN AND METHODSExpression of macrophage markers in adipose tissue was analyzed by DNA microarrays in the SOS Sib Pair study and in patients with type 2 diabetes and a BMI-matched healthy control group.The expression of macrophage markers in adipose tissue was increased in obesity and associated with several metabolic and anthropometric measurements. After adjustment for BMI, the expression remained associated with insulin sensitivity, serum levels of insulin, C-peptide, high density lipoprotein cholesterol (HDL-cholesterol) and triglycerides. In addition, the expression of most macrophage markers was significantly increased in patients with type 2 diabetes compared to the control group.RESULTSThe expression of macrophage markers in adipose tissue was increased in obesity and associated with several metabolic and anthropometric measurements. After adjustment for BMI, the expression remained associated with insulin sensitivity, serum levels of insulin, C-peptide, high density lipoprotein cholesterol (HDL-cholesterol) and triglycerides. In addition, the expression of most macrophage markers was significantly increased in patients with type 2 diabetes compared to the control group.Our study shows that infiltration of macrophages in human adipose tissue, estimated by the expression of macrophage markers, is increased in subjects with obesity and diabetes and associated with insulin sensitivity and serum lipid levels independent of BMI. This indicates that adipose tissue macrophages may contribute to the development of insulin resistance and dyslipidemia.CONCLUSIONOur study shows that infiltration of macrophages in human adipose tissue, estimated by the expression of macrophage markers, is increased in subjects with obesity and diabetes and associated with insulin sensitivity and serum lipid levels independent of BMI. This indicates that adipose tissue macrophages may contribute to the development of insulin resistance and dyslipidemia. Obesity is linked to both increased metabolic disturbances and increased adipose tissue macrophage infiltration. However, whether macrophage infiltration directly influences human metabolism is unclear. The aim of this study was to investigate if there are obesity-independent links between adipose tissue macrophages and metabolic disturbances. Expression of macrophage markers in adipose tissue was analyzed by DNA microarrays in the SOS Sib Pair study and in patients with type 2 diabetes and a BMI-matched healthy control group. The expression of macrophage markers in adipose tissue was increased in obesity and associated with several metabolic and anthropometric measurements. After adjustment for BMI, the expression remained associated with insulin sensitivity, serum levels of insulin, C-peptide, high density lipoprotein cholesterol (HDL-cholesterol) and triglycerides. In addition, the expression of most macrophage markers was significantly increased in patients with type 2 diabetes compared to the control group. Our study shows that infiltration of macrophages in human adipose tissue, estimated by the expression of macrophage markers, is increased in subjects with obesity and diabetes and associated with insulin sensitivity and serum lipid levels independent of BMI. This indicates that adipose tissue macrophages may contribute to the development of insulin resistance and dyslipidemia. Obesity is linked to both increased metabolic disturbances and increased adipose tissue macrophage infiltration. However, whether macrophage infiltration directly influences human metabolism is unclear. The aim of this study was to investigate if there are obesity-independent links between adipose tissue macrophages and metabolic disturbances. Expression of macrophage markers in adipose tissue was analyzed by DNA microarrays in the SOS Sib Pair study and in patients with type 2 diabetes and a BMI-matched healthy control group. The expression of macrophage markers in adipose tissue was increased in obesity and associated with several metabolic and anthropometric measurements. After adjustment for BMI, the expression remained associated with insulin sensitivity, serum levels of insulin, C-peptide, high density lipoprotein cholesterol (HDL-cholesterol) and triglycerides. In addition, the expression of most macrophage markers was significantly increased in patients with type 2 diabetes compared to the control group. Our study shows that infiltration of macrophages in human adipose tissue, estimated by the expression of macrophage markers, is increased in subjects with obesity and diabetes and associated with insulin sensitivity and serum lipid levels independent of BMI. This indicates that adipose tissue macrophages may contribute to the development of insulin resistance and dyslipidemia. Objective: Obesity is linked to both increased metabolic disturbances and increased adipose tissue macrophage infiltration. However, whether macrophage infiltration directly influences human metabolism is unclear. The aim of this study was to investigate if there are obesity‐independent links between adipose tissue macrophages and metabolic disturbances. Design and Methods: Expression of macrophage markers in adipose tissue was analyzed by DNA microarrays in the SOS Sib Pair study and in patients with type 2 diabetes and a BMI‐matched healthy control group. Results: The expression of macrophage markers in adipose tissue was increased in obesity and associated with several metabolic and anthropometric measurements. After adjustment for BMI, the expression remained associated with insulin sensitivity, serum levels of insulin, C‐peptide, high density lipoprotein cholesterol (HDL‐cholesterol) and triglycerides. In addition, the expression of most macrophage markers was significantly increased in patients with type 2 diabetes compared to the control group. Conclusion: Our study shows that infiltration of macrophages in human adipose tissue, estimated by the expression of macrophage markers, is increased in subjects with obesity and diabetes and associated with insulin sensitivity and serum lipid levels independent of BMI. This indicates that adipose tissue macrophages may contribute to the development of insulin resistance and dyslipidemia. Objective: Obesity is linked to both increased metabolic disturbances and increased adipose tissue macrophage infiltration. However, whether macrophage infiltration directly influences human metabolism is unclear. The aim of this study was to investigate if there are obesity‐independent links between adipose tissue macrophages and metabolic disturbances. Design and Methods: Expression of macrophage markers in adipose tissue was analyzed by DNA microarrays in the SOS Sib Pair study and in patients with type 2 diabetes and a BMI‐matched healthy control group. Results: The expression of macrophage markers in adipose tissue was increased in obesity and associated with several metabolic and anthropometric measurements. After adjustment for BMI, the expression remained associated with insulin sensitivity, serum levels of insulin, C‐peptide, high density lipoprotein cholesterol (HDL‐cholesterol) and triglycerides. In addition, the expression of most macrophage markers was significantly increased in patients with type 2 diabetes compared to the control group. Conclusion: Our study shows that infiltration of macrophages in human adipose tissue, estimated by the expression of macrophage markers, is increased in subjects with obesity and diabetes and associated with insulin sensitivity and serum lipid levels independent of BMI. This indicates that adipose tissue macrophages may contribute to the development of insulin resistance and dyslipidemia. |
Author | Sjöholm, K. Andersson‐Assarsson, J.C. Prifti, E. Jacobson, P. Walley, A. Borén, J. Svensson, P.‐A. Bergman, R.N. Froguel, P. Carlsson, L.M.S. Ahlin, S. Poitou, C. Jansson, P.‐A. Olsson, B. Sjöström, L. Tordjman, J. |
AuthorAffiliation | 1 Sahlgrenska Center for Cardiovascular and Metabolic Research, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at the University of Gothenburg, 413 45 Gothenburg, Sweden 2 Department of Genomics of Common Disease, School of Public Health, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom 4 Cedars-Sinai Diabetes and Obesity Research Institute, 8700 Beverly Blvd, Thalians E104, Los Angeles, CA 90048 3 Inserm, U872, 15, rue de l’École de Medecine, 75007 Paris, F-75006 France, Universite Pierre et Marie Curie-Paris 6, Centre de Recherche des Cordeliers, UMRS 872, Paris, F-75006 France 5 Clinical Neurochemistry Laboratory, Department of Neurochemistry and Psychiatry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, 431 80 Mölndal, Sweden |
AuthorAffiliation_xml | – name: 2 Department of Genomics of Common Disease, School of Public Health, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom – name: 1 Sahlgrenska Center for Cardiovascular and Metabolic Research, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at the University of Gothenburg, 413 45 Gothenburg, Sweden – name: 4 Cedars-Sinai Diabetes and Obesity Research Institute, 8700 Beverly Blvd, Thalians E104, Los Angeles, CA 90048 – name: 5 Clinical Neurochemistry Laboratory, Department of Neurochemistry and Psychiatry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, 431 80 Mölndal, Sweden – name: 3 Inserm, U872, 15, rue de l’École de Medecine, 75007 Paris, F-75006 France, Universite Pierre et Marie Curie-Paris 6, Centre de Recherche des Cordeliers, UMRS 872, Paris, F-75006 France |
Author_xml | – sequence: 1 givenname: S. surname: Ahlin fullname: Ahlin, S. organization: Sahlgrenska Center for Cardiovascular and Metabolic Research, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at the University of Gothenburg – sequence: 2 givenname: K. surname: Sjöholm fullname: Sjöholm, K. organization: Sahlgrenska Center for Cardiovascular and Metabolic Research, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at the University of Gothenburg – sequence: 3 givenname: P. surname: Jacobson fullname: Jacobson, P. organization: Sahlgrenska Center for Cardiovascular and Metabolic Research, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at the University of Gothenburg – sequence: 4 givenname: J.C. surname: Andersson‐Assarsson fullname: Andersson‐Assarsson, J.C. organization: Sahlgrenska Center for Cardiovascular and Metabolic Research, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at the University of Gothenburg – sequence: 5 givenname: A. surname: Walley fullname: Walley, A. organization: Department of Genomics of Common Disease, School of Public Health, Imperial College London, Hammersmith Hospital – sequence: 6 givenname: J. surname: Tordjman fullname: Tordjman, J. organization: Université Paris Descartes‐Paris 5, UMRS 872 – sequence: 7 givenname: C. surname: Poitou fullname: Poitou, C. organization: Université Paris Descartes‐Paris 5, UMRS 872 – sequence: 8 givenname: E. surname: Prifti fullname: Prifti, E. organization: Université Paris Descartes‐Paris 5, UMRS 872 – sequence: 9 givenname: P.‐A. surname: Jansson fullname: Jansson, P.‐A. organization: Sahlgrenska Center for Cardiovascular and Metabolic Research, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at the University of Gothenburg – sequence: 10 givenname: J. surname: Borén fullname: Borén, J. organization: Sahlgrenska Center for Cardiovascular and Metabolic Research, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at the University of Gothenburg – sequence: 11 givenname: L. surname: Sjöström fullname: Sjöström, L. organization: Sahlgrenska Center for Cardiovascular and Metabolic Research, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at the University of Gothenburg – sequence: 12 givenname: P. surname: Froguel fullname: Froguel, P. organization: Department of Genomics of Common Disease, School of Public Health, Imperial College London, Hammersmith Hospital – sequence: 13 givenname: R.N. surname: Bergman fullname: Bergman, R.N. organization: Department of Biomedical Sciences and Department of Medicine, Cedars‐Sinai Diabetes and Obesity Research Institute – sequence: 14 givenname: L.M.S. surname: Carlsson fullname: Carlsson, L.M.S. organization: Sahlgrenska Center for Cardiovascular and Metabolic Research, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at the University of Gothenburg – sequence: 15 givenname: B. surname: Olsson fullname: Olsson, B. organization: The Sahlgrenska Academy at University of Gothenburg – sequence: 16 givenname: P.‐A. surname: Svensson fullname: Svensson, P.‐A. organization: Sahlgrenska Center for Cardiovascular and Metabolic Research, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at the University of Gothenburg |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23512687$$D View this record in MEDLINE/PubMed https://gup.ub.gu.se/publication/181112$$DView record from Swedish Publication Index |
BookMark | eNp1kk9v1DAQxSNURP_AgS-ALHGBQ1qPnXidC9JSlVJp0R4oEpwsJ5nsusraaSbZZY98c1x2W9EKLrbH_r2nJ88cJwc-eEyS18BPgXNxFsrtqeBZJp8lR1BInk5k8f3g4azhMDkmuuE8UzyHF8mhkDkIpSdHya8vtupDt7QLZJfokV387HokcsEz59m0dl0gZNeOaETmiE2JQuXsgDXbuGHJrjyNbSS_oic3uLUbtsz6Otb9uGIz17mazXCNLUW0xg7j4gcWGjYvMSq2L5PnjW0JX-33k-Tbp4vr88_pbH55dT6dpVWmQaZ5pQqJmS5l3uS5akDWRVMrrmtlJ2VZyRIaJXIBoilAo9SqwrLJaiyFsIWw8iRJd760wW4sTde7le23JlhnFmNn4tViNIQGNACIyH_Y8RFeYV3F1L1tH8kev3i3NIuwNnKiZKF0NHi3N-jD7Yg0mJWjCtvWegwjGchUDlpkxR369gl6E8bex-8woCY5B8h0Eak3fyd6iHLfzQic7YDYUqIeG1O5wQ6xlzGgaw1wczcvJs6L-TMvUfH-ieLe9F_s3n3jWtz-HzTzjz92it8dxNHj |
CitedBy_id | crossref_primary_10_1002_osp4_541 crossref_primary_10_3389_fendo_2022_873699 crossref_primary_10_1021_acs_analchem_5b03696 crossref_primary_10_14814_phy2_13183 crossref_primary_10_2337_db20_0096 crossref_primary_10_1074_jbc_M113_515320 crossref_primary_10_1002_oby_20991 crossref_primary_10_3390_nu11102493 crossref_primary_10_14814_phy2_13019 crossref_primary_10_1186_s41231_022_00119_3 crossref_primary_10_1016_j_bbrc_2014_03_075 crossref_primary_10_1016_j_molmet_2017_07_008 crossref_primary_10_1016_j_trsl_2016_01_002 crossref_primary_10_1042_CS20200173 crossref_primary_10_3389_fimmu_2023_1153915 crossref_primary_10_1002_biof_1317 crossref_primary_10_1038_mtna_2015_51 |
Cites_doi | 10.1038/ijo.2008.238 10.1038/sj.ijo.0803744 10.2337/diabetes.54.8.2305 10.1016/j.atherosclerosis.2004.07.031 10.2337/db08-0604 10.1056/NEJMoa035622 10.1172/JCI29881 10.1016/j.bbrc.2009.03.014 10.1001/jama.282.22.2131 10.1161/CIRCULATIONAHA.107.724096 10.1089/152091503322641060 10.2337/db06-0133 10.1016/j.atherosclerosis.2010.12.018 10.1194/jlr.M500294-JLR200 10.1038/sj.ijo.0803632 10.1016/j.soard.2010.05.013 10.2337/diabetes.54.8.2277 10.1093/nar/gng015 10.1210/jc.2009-0925 10.1210/jc.2009-0292 10.1172/JCI26498 10.1097/01.hjr.0000114707.27531.48 10.2337/db08-0536 10.1016/j.febslet.2007.11.057 10.1152/ajpendo.1979.236.6.E667 10.1172/JCI24335 10.1097/MED.0b013e328357f0a3 10.1172/JCI200319451 10.1161/01.ATV.0000111245.75752.C6 10.1210/jc.2006-1811 10.1016/S0140-6736(05)67483-1 10.1001/jama.286.10.1195 10.1016/j.jpeds.2008.01.006 10.1172/JCI200319246 10.2337/db09-0287 10.1001/jama.298.17.2028 10.1056/NEJMoa0801891 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 10.1152/ajpendo.1987.253.6.E595 |
ContentType | Journal Article |
Copyright | Copyright © 2013 The Obesity Society Copyright © 2013 The Obesity Society. Copyright Blackwell Publishing Ltd. Dec 2013 |
Copyright_xml | – notice: Copyright © 2013 The Obesity Society – notice: Copyright © 2013 The Obesity Society. – notice: Copyright Blackwell Publishing Ltd. Dec 2013 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 5PM ADTPV AOWAS F1U |
DOI | 10.1002/oby.20443 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) SwePub SwePub Articles SWEPUB Göteborgs universitet |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1930-739X |
EndPage | E576 |
ExternalDocumentID | oai_gup_ub_gu_se_181112 PMC3763968 3663323431 23512687 10_1002_oby_20443 OBY20443 |
Genre | article Research Support, Non-U.S. Gov't Journal Article Feature |
GeographicLocations | Sweden |
GeographicLocations_xml | – name: Sweden |
GrantInformation_xml | – fundername: Swedish federal government under the LUA/ALF agreement – fundername: Swedish Diabetes Foundation – fundername: Tore Nilsson Foundation – fundername: Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research – fundername: INSERM and the FLIP7th framework program – fundername: Hepadip consortium – fundername: Swedish Research Council funderid: K2008‐65X‐20753‐01‐4; K2009‐65X‐15424‐05‐3; K2010‐55X‐11285‐13 – fundername: Royal Physiographic Society (Nilsson‐Ehle Foundation) – fundername: Torsten and Ragnar Söderberg Foundation – fundername: Contrat de Recherche Clinique (CRIC to CP) – fundername: Wellcome Trust grantid: 079534 – fundername: Medical Research Council grantid: G1002084 – fundername: Wellcome Trust grantid: GR079534 – fundername: Wellcome Trust : grantid: 079534 || WT |
GroupedDBID | --- 05W 0R~ 123 1OC 24P 29N 2FS 2WC 31~ 33P 39C 3SF 3V. 4.4 50Y 52U 52V 53G 70F 7X7 8-1 8C1 A00 AAESR AAEVG AAFWJ AAHBH AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCUV ABIVO ABJNI ABLJU ABQWH ABXGK ACAHQ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFKRA AFPWT AFWVQ AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZQEC AZVAB BAWUL BENPR BFHJK BHBCM BKNYI BMXJE BOGZA BPHCQ BRXPI BVXVI CS3 DCZOG DIK DPXWK DRFUL DRMAN DRSTM DU5 E3Z EBS EJD EMOBN F5P FUBAC FYUFA G-S GODZA HGLYW HZ~ KBYEO LATKE LEEKS LH4 LITHE LOXES LUTES LW6 LYRES M0R M1P MEWTI MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ O66 O9- OK1 P2W PQQKQ PROAC PSQYO R.K ROL SUPJJ UKHRP WBKPD WHG WHWMO WIH WIJ WIK WIN WOHZO WOQ WQJ WVDHM WXSBR WYJ YHZ AAYXX AEYWJ AGHNM AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM K9. 7X8 5PM ADTPV AOWAS F1U |
ID | FETCH-LOGICAL-c4813-5c693e48b35f556f13d9fd608d6a7bbc3b1f625212f918e386cebf4deb22a92a3 |
ISSN | 1930-7381 1930-739X |
IngestDate | Thu Aug 21 06:28:30 EDT 2025 Thu Aug 21 14:03:53 EDT 2025 Fri Jul 11 12:11:32 EDT 2025 Fri Jul 25 23:50:28 EDT 2025 Mon Jul 21 05:30:28 EDT 2025 Tue Jul 01 01:16:10 EDT 2025 Thu Apr 24 23:05:11 EDT 2025 Wed Jan 22 16:55:56 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
License | Copyright © 2013 The Obesity Society. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4813-5c693e48b35f556f13d9fd608d6a7bbc3b1f625212f918e386cebf4deb22a92a3 |
Notes | B. Olsson and P.‐A. Svensson contributed equally to this work. Disclosure: The authors declared no conflict of interest. B. Olsson and P.‐A. Svensson contributed equally to this work. SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 Both authors contributed equally |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC3763968 |
PMID | 23512687 |
PQID | 1675011489 |
PQPubID | 105348 |
PageCount | 6 |
ParticipantIDs | swepub_primary_oai_gup_ub_gu_se_181112 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3763968 proquest_miscellaneous_1465182498 proquest_journals_1675011489 pubmed_primary_23512687 crossref_citationtrail_10_1002_oby_20443 crossref_primary_10_1002_oby_20443 wiley_primary_10_1002_oby_20443_OBY20443 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | December 2013 |
PublicationDateYYYYMMDD | 2013-12-01 |
PublicationDate_xml | – month: 12 year: 2013 text: December 2013 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Silver Spring |
PublicationTitle | Obesity (Silver Spring, Md.) |
PublicationTitleAlternate | Obesity (Silver Spring) |
PublicationYear | 2013 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | 2001; 286 2006; 55 2004; 24 2008; 57 2007; 92 2012; 19 2008; 32 215 2006; 116 2007; 31 2003; 112 2008; 582 2003; 31 2005; 46 2004; 11 1998; 15 2004; 177 2009; 58 2004; 351 1979; 236 59 1987; 253 2007; 117 2009; 94 2005; 366 2007; 298 1999; 282 2008; 359 2008; 117 2005; 54 2003; 5 2009; 382 7 2008; 153 e_1_2_6_32_1 e_1_2_6_10_1 e_1_2_6_31_1 e_1_2_6_30_1 e_1_2_6_19_1 e_1_2_6_13_1 e_1_2_6_36_1 e_1_2_6_14_1 e_1_2_6_35_1 e_1_2_6_11_1 e_1_2_6_12_1 e_1_2_6_33_1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_15_1 e_1_2_6_16_1 e_1_2_6_37_1 e_1_2_6_21_1 e_1_2_6_20_1 e_1_2_6_40_1 Wentworth JM (e_1_2_6_38_1); 59 Hardy OT (e_1_2_6_39_1); 7 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_25_1 He J (e_1_2_6_34_1); 215 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_22_1 e_1_2_6_29_1 e_1_2_6_28_1 e_1_2_6_27_1 e_1_2_6_26_1 |
References_xml | – volume: 117 start-page: 806 year: 2008 end-page: 815 article-title: Remodeling phenotype of human subcutaneous adipose tissue macrophages publication-title: Circulation – volume: 351 start-page: 2683 year: 2004 end-page: 2693 article-title: Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery publication-title: N Engl J Med – volume: 253 start-page: E595 year: 1987 end-page: E602 article-title: Modified protocols improve insulin sensitivity estimation using the minimal model publication-title: Am J Physiol – volume: 153 start-page: 71 year: 2008 end-page: 75 article-title: Serum amyloid A concentration is increased in obese children and adolescents publication-title: J Pediatr – volume: 54 start-page: 2277 year: 2005 end-page: 2286 article-title: Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery‐induced weight loss publication-title: Diabetes – volume: 116 start-page: 115 year: 2006 end-page: 124 article-title: CCR2 modulates inflammatory and metabolic effects of high‐fat feeding publication-title: J Clin Invest – volume: 19 start-page: 341 year: 2012 end-page: 346 article-title: Are there still healthy obese patients? publication-title: Curr Opin Endocrinol Diabetes Obes – volume: 7 start-page: 60 end-page: 67 article-title: Body mass index‐independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity publication-title: Surg Obes Relat Dis – volume: 582 start-page: 97 year: 2008 end-page: 105 article-title: Inflammation and insulin resistance publication-title: FEBS Lett – volume: 112 start-page: 1796 year: 2003 end-page: 1808 article-title: Obesity is associated with macrophage accumulation in adipose tissue publication-title: J Clin Invest – volume: 46 start-page: 2347 year: 2005 end-page: 2355 article-title: Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans publication-title: J Lipid Res – volume: 58 start-page: 385 year: 2009 end-page: 393 article-title: Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole‐body insulin action in healthy Pima Indians publication-title: Diabetes – volume: 177 start-page: 287 year: 2004 end-page: 290 article-title: Identification of genes predominantly expressed in human macrophages publication-title: Atherosclerosis – volume: 11 start-page: 3 year: 2004 end-page: 8 article-title: The obesity epidemic, metabolic syndrome and future prevention strategies publication-title: Eur J Cardiovasc Prev Rehabil – volume: 282 start-page: 2131 year: 1999 end-page: 2135 article-title: Elevated C‐reactive protein levels in overweight and obese adults publication-title: JAMA – volume: 94 start-page: 4619 year: 2009 end-page: 4623 article-title: Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss publication-title: J Clin Endocrinol Metab – volume: 286 start-page: 1195 year: 2001 end-page: 1200 article-title: The continuing epidemics of obesity and diabetes in the United States publication-title: JAMA – volume: 215 start-page: 243 end-page: 246 article-title: Markers of adipose tissue macrophage content are negatively associated with serum HDL‐C concentrations publication-title: Atherosclerosis – volume: 55 start-page: 1554 year: 2006 end-page: 1561 article-title: Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity publication-title: Diabetes – volume: 116 start-page: 1494 year: 2006 end-page: 1505 article-title: MCP‐1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity publication-title: J Clin Invest – volume: 32 start-page: S52 issue: Suppl 7 year: 2008 end-page: S54 article-title: Inflammation and endoplasmic reticulum stress in obesity and diabetes publication-title: Int J Obes (Lond) – volume: 94 start-page: 3987 year: 2009 end-page: 3994 article-title: Tenomodulin is highly expressed in adipose tissue, increased in obesity, and down‐regulated during diet‐induced weight loss publication-title: J Clin Endocrinol Metab – volume: 57 start-page: 2438 year: 2008 end-page: 2444 article-title: Increase in endoplasmic reticulum stress‐related proteins and genes in adipose tissue of obese, insulin‐resistant individuals publication-title: Diabetes – volume: 382 start-page: 309 year: 2009 end-page: 314 article-title: ALK7 expression is specific for adipose tissue, reduced in obesity and correlates to factors implicated in metabolic disease publication-title: Biochem Biophys Res Commun – volume: 366 start-page: 1197 year: 2005 end-page: 1209 article-title: Obesity publication-title: Lancet – volume: 15 start-page: 539 year: 1998 end-page: 553 article-title: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation publication-title: Diabet Med – volume: 24 start-page: e13 year: 2004 article-title: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition publication-title: Arterioscler Thromb Vasc Biol – volume: 117 start-page: 175 year: 2007 end-page: 184 article-title: Obesity induces a phenotypic switch in adipose tissue macrophage polarization publication-title: J Clin Invest – volume: 54 start-page: 2305 year: 2005 end-page: 2313 article-title: Expression of CD68 and macrophage chemoattractant protein‐1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone publication-title: Diabetes – volume: 298 start-page: 2028 year: 2007 end-page: 2037 article-title: Cause‐specific excess deaths associated with underweight, overweight, and obesity publication-title: JAMA – volume: 59 start-page: 1648 end-page: 1656 article-title: Proinflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity publication-title: Diabetes – volume: 32 start-page: 451 year: 2008 end-page: 463 article-title: Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T‐cell infiltration publication-title: Int J Obes (Lond) – volume: 92 start-page: 2240 year: 2007 end-page: 2247 article-title: Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity publication-title: J Clin Endocrinol Metab – volume: 359 start-page: 2105 year: 2008 end-page: 2120 article-title: General and abdominal adiposity and risk of death in Europe publication-title: N Engl J Med – volume: 5 start-page: 1003 year: 2003 end-page: 1015 article-title: MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test publication-title: Diabetes Technol Ther – volume: 112 start-page: 1821 year: 2003 end-page: 1830 article-title: Chronic inflammation in fat plays a crucial role in the development of obesity‐related insulin resistance publication-title: J Clin Invest – volume: 31 start-page: 1420 year: 2007 end-page: 1428 article-title: Human adipose tissue macrophages are of an anti‐inflammatory phenotype but capable of excessive pro‐inflammatory mediator production publication-title: Int J Obes (Lond) – volume: 236 start-page: E667 year: 1979 end-page: E677 article-title: Quantitative estimation of insulin sensitivity publication-title: Am J Physiol – volume: 31 start-page: e15 year: 2003 article-title: Summaries of affymetrix GeneChip probe level data publication-title: Nucleic Acids Res – ident: e_1_2_6_16_1 doi: 10.1038/ijo.2008.238 – ident: e_1_2_6_14_1 doi: 10.1038/sj.ijo.0803744 – ident: e_1_2_6_40_1 doi: 10.2337/diabetes.54.8.2305 – ident: e_1_2_6_32_1 doi: 10.1016/j.atherosclerosis.2004.07.031 – ident: e_1_2_6_15_1 doi: 10.2337/db08-0604 – ident: e_1_2_6_23_1 doi: 10.1056/NEJMoa035622 – ident: e_1_2_6_18_1 doi: 10.1172/JCI29881 – ident: e_1_2_6_25_1 doi: 10.1016/j.bbrc.2009.03.014 – ident: e_1_2_6_9_1 doi: 10.1001/jama.282.22.2131 – ident: e_1_2_6_20_1 doi: 10.1161/CIRCULATIONAHA.107.724096 – ident: e_1_2_6_29_1 doi: 10.1089/152091503322641060 – ident: e_1_2_6_37_1 doi: 10.2337/db06-0133 – volume: 215 start-page: 243 ident: e_1_2_6_34_1 article-title: Markers of adipose tissue macrophage content are negatively associated with serum HDL‐C concentrations publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2010.12.018 – ident: e_1_2_6_17_1 doi: 10.1194/jlr.M500294-JLR200 – ident: e_1_2_6_21_1 doi: 10.1038/sj.ijo.0803632 – volume: 7 start-page: 60 ident: e_1_2_6_39_1 article-title: Body mass index‐independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity publication-title: Surg Obes Relat Dis doi: 10.1016/j.soard.2010.05.013 – ident: e_1_2_6_22_1 doi: 10.2337/diabetes.54.8.2277 – ident: e_1_2_6_26_1 doi: 10.1093/nar/gng015 – ident: e_1_2_6_19_1 doi: 10.1210/jc.2009-0925 – ident: e_1_2_6_24_1 doi: 10.1210/jc.2009-0292 – ident: e_1_2_6_13_1 doi: 10.1172/JCI26498 – ident: e_1_2_6_3_1 doi: 10.1097/01.hjr.0000114707.27531.48 – ident: e_1_2_6_31_1 doi: 10.2337/db08-0536 – ident: e_1_2_6_12_1 doi: 10.1016/j.febslet.2007.11.057 – ident: e_1_2_6_27_1 doi: 10.1152/ajpendo.1979.236.6.E667 – ident: e_1_2_6_36_1 doi: 10.1172/JCI24335 – ident: e_1_2_6_35_1 doi: 10.1097/MED.0b013e328357f0a3 – ident: e_1_2_6_11_1 doi: 10.1172/JCI200319451 – ident: e_1_2_6_6_1 doi: 10.1161/01.ATV.0000111245.75752.C6 – ident: e_1_2_6_33_1 doi: 10.1210/jc.2006-1811 – ident: e_1_2_6_4_1 doi: 10.1016/S0140-6736(05)67483-1 – ident: e_1_2_6_2_1 doi: 10.1001/jama.286.10.1195 – ident: e_1_2_6_8_1 doi: 10.1016/j.jpeds.2008.01.006 – ident: e_1_2_6_10_1 doi: 10.1172/JCI200319246 – volume: 59 start-page: 1648 ident: e_1_2_6_38_1 article-title: Proinflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity publication-title: Diabetes doi: 10.2337/db09-0287 – ident: e_1_2_6_5_1 doi: 10.1001/jama.298.17.2028 – ident: e_1_2_6_7_1 doi: 10.1056/NEJMoa0801891 – ident: e_1_2_6_30_1 doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S – ident: e_1_2_6_28_1 doi: 10.1152/ajpendo.1987.253.6.E595 |
SSID | ssj0046051 |
Score | 2.190011 |
Snippet | Objective: Obesity is linked to both increased metabolic disturbances and increased adipose tissue macrophage infiltration. However, whether macrophage... Objective: Obesity is linked to both increased metabolic disturbances and increased adipose tissue macrophage infiltration. However, whether macrophage... Obesity is linked to both increased metabolic disturbances and increased adipose tissue macrophage infiltration. However, whether macrophage infiltration... |
SourceID | swepub pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | E571 |
SubjectTerms | Adipose Tissue - metabolism Body fat Body Mass Index C-Peptide - blood Case-Control Studies Cholesterol, HDL - blood Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - genetics Endocrinology and Diabetes Endokrinologi och diabetes Female Gene Expression Genetic Markers Humans Insulin Insulin - blood Insulin resistance Insulin Resistance - genetics Macrophages - metabolism Male Metabolic disorders Obesity Obesity - blood Obesity - genetics Oligonucleotide Array Sequence Analysis Rodents Studies Triglycerides - blood |
Title | Macrophage Gene Expression in Adipose Tissue is Associated with Insulin Sensitivity and Serum Lipid Levels Independent of Obesity |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Foby.20443 https://www.ncbi.nlm.nih.gov/pubmed/23512687 https://www.proquest.com/docview/1675011489 https://www.proquest.com/docview/1465182498 https://pubmed.ncbi.nlm.nih.gov/PMC3763968 https://gup.ub.gu.se/publication/181112 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLfKkBAXxDeFgQxCCKnKltiJax836DTGuh1opXKy8uGsQaWt1uYAN0782zx_JE3UIg0uVeS4aeP3i_3ey8_vh9DbTHAepD71MsaZF6ow9DijiZcRkqbKVyJI9Ebh4QU7HYdnk2jS6fxusJbKdXKQ_ty5r-R_rAptYFe9S_YfLFtfFBrgGOwLn2Bh-LyRjYexFuCaatoN9FG6XL-ltRr6YpwVS81GX5ux1crlsbNFRTmviOgrzWJ3MhImka6uy--9WbEsst5Ms4o0aauSyzXUgYXVE2i6tk5iQLusXwrNt-7ZpKFJuWYHzZTD1KnEbyTAvukX9sesStHWudczmLArhfN6J9qR2ZADrR6AKzZHBowu4-tyGAFt8EHstCuo7_WpEdWFVWlHm5urSdDEJGnMvIPISrlsLQm2xOwi-XFA_NCWhGqX3b64lCfj83M5GkxGt9BtAvGGlsL4-OlztaTrd8eBpSfYv1SVqPLJYX3htmOzFa1sk25dadp2VGTcmtF9dM_FI_jIgusB6qj5Q3Rn6BgXj9CvDcawxhjeYAwXc-wwhi3GcLHCG4xhjTHsMIYbGMOAMWwwhg3GsMUYbmAML3LsMPYYjU8Gow-nnpPt8NKQg22jlAmqQp7QKI8ilgc0E3nGfJ6xuJ8kKU2CHKJu8JlyEXBFOUuVpouqhJBYkJg-QXvzxVw9QxjCPxjaCCwCfr-gUcxYphSEJKovfJ6wLnpfjblMXU17La0yk7YaN5FgHmnM00Vv6q5LW8hlV6f9ynDSPecrGUBMbdIGoote16dhFtav1uK5WpQrHUBHEKmHgnfRU2vn-lcIBaea8X4X9VsIqDvoCu_tM_Niaiq969VfMLjmO4uV1leuyqWEpqtSrpQERx0iJxgPg6W_36G8PP5qDp7f4F5eoLubp3Uf7a2vS_USfPB18so8H38AGE3jDw |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Macrophage+gene+expression+in+adipose+tissue+is+associated+with+insulin+sensitivity+and+serum+lipid+levels+independent+of+obesity&rft.jtitle=Obesity+%28Silver+Spring%2C+Md.%29&rft.au=Ahlin%2C+S&rft.au=Sj%C3%B6holm%2C+K&rft.au=Jacobson%2C+P&rft.au=Andersson-Assarsson%2C+J+C&rft.date=2013-12-01&rft.issn=1930-739X&rft.eissn=1930-739X&rft.volume=21&rft.issue=12&rft.spage=E571&rft_id=info:doi/10.1002%2Foby.20443&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1930-7381&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1930-7381&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1930-7381&client=summon |